{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:36:22Z","timestamp":1789130182779,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1681\/asn.2014050429","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:31:22Z","timestamp":1420763482000},"page":"2239-2247","source":"Crossref","is-referenced-by-count":109,"title":["Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy"],"prefix":"10.1681","volume":"26","author":[{"given":"Jamie S.","family":"Chua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"Baelde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malu","family":"Zandbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Wilhelmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leendert A.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Bruijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg M.","family":"Bajema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230208","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies.","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-21-20230208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.ki.5001535","article-title":"The molecular biology of thrombotic microangiopathy.","volume":"70","author":"Tsai","year":"2006","journal-title":"Kidney Int"},{"key":"R3-21-20230208","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders.","volume":"70","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"key":"R4-21-20230208","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy.","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"R5-21-20230208","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation.","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R6-21-20230208","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R7-21-20230208","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"R8-21-20230208","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1160\/TH04-07-0450","article-title":"Complement activation: The missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.","volume":"93","author":"Ruiz-Torres","year":"2005","journal-title":"Thromb Haemost"},{"key":"R9-21-20230208","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/art.23662","article-title":"Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R10-21-20230208","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2009-01-199117","article-title":"Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies.","volume":"114","author":"Seshan","year":"2009","journal-title":"Blood"},{"key":"R11-21-20230208","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies\u2014role of antibody-mediated rejection.","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"key":"R12-21-20230208","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09084.x","article-title":"Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura.","volume":"157","author":"Chapin","year":"2012","journal-title":"Br J Haematol"},{"key":"R13-21-20230208","doi-asserted-by":"crossref","first-page":"E216","DOI":"10.1111\/ctr.12102","article-title":"The use of eculizumab in renal transplantation.","volume":"27","author":"Barnett","year":"2013","journal-title":"Clin Transplant"},{"key":"R14-21-20230208","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/TP.0b013e318230c0bd","article-title":"Successful treatment of de novo posttransplant thrombotic microangiopathy with eculizumab.","volume":"92","author":"Wilson","year":"2011","journal-title":"Transplantation"},{"key":"R15-21-20230208","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1600-6143.2011.03696.x","article-title":"Eculizumab in acute recurrence of thrombotic microangiopathy after renal transplantation.","volume":"11","author":"Hadaya","year":"2011","journal-title":"Am J Transplant"},{"key":"R16-21-20230208","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS.","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"R17-21-20230208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/MOP.0b013e32835df4a3","article-title":"Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.","volume":"25","author":"Nester","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"R18-21-20230208","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R19-21-20230208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis.","volume":"18","author":"Colvin","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R20-21-20230208","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/modpathol.2008.152","article-title":"Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney.","volume":"21","author":"Batal","year":"2008","journal-title":"Mod Pathol"},{"key":"R21-21-20230208","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/TP.0b013e3182052be8","article-title":"Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies.","volume":"91","author":"Kiki\u0107","year":"2011","journal-title":"Transplantation"},{"key":"R22-21-20230208","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"key":"R23-21-20230208","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ki.2011.497","article-title":"Pros and cons for C4d as a biomarker.","volume":"81","author":"Cohen","year":"2012","journal-title":"Kidney Int"},{"key":"R24-21-20230208","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/0961203310368409","article-title":"Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: A prospective study of 155 cases.","volume":"19","author":"Shen","year":"2010","journal-title":"Lupus"},{"key":"R25-21-20230208","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","article-title":"Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"key":"R26-21-20230208","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mpdhp.2013.02.004","article-title":"Thrombotic microangiopathy and the kidney: A nephropathologist's perspective.","volume":"19","author":"Chang","year":"2013","journal-title":"Diagn Histopathol"},{"key":"R27-21-20230208","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/TP.0b013e31827e31c9","article-title":"Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantation.","volume":"95","author":"de Vries","year":"2013","journal-title":"Transplantation"},{"key":"R28-21-20230208","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1084\/jem.183.5.2343","article-title":"Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.","volume":"183","author":"Weiser","year":"1996","journal-title":"J Exp Med"},{"key":"R29-21-20230208","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1152\/jappl.1999.86.3.938","article-title":"Intestinal reperfusion injury is mediated by IgM and complement.","volume":"86","author":"Williams","year":"1999","journal-title":"J Appl Physiol (1985"},{"key":"R30-21-20230208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1523-1755.2003.00737.x","article-title":"A small molecule C5a receptor antagonist protects kidneys from ischemia\/reperfusion injury in rats.","volume":"63","author":"Arumugam","year":"2003","journal-title":"Kidney Int"},{"key":"R31-21-20230208","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: Updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201509000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:50Z","timestamp":1786130810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201509000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014050429","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}